Unknown

Dataset Information

Ruxolitinib partially reverses functional natural killer cell deficiency in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations.


ABSTRACT:

Background

Natural killer (NK) cells are critical innate effector cells whose development is dependent on the Janus kinase-signal transducer and activator of transcription (STAT) pathway. NK cell deficiency can result in severe or refractory viral infections. Patients with STAT1 gain-of-function (GOF) mutations have increased viral susceptibility.

Objective

We sought to investigate NK cell function in patients with STAT1 GOF mutations.

Methods

NK cell phenotype and function were determined in 16 patients with STAT1 GOF mutations. NK cell lines expressing patients' mutations were generated with clustered regularly interspaced short palindromic repeats (CRISPR-Cas9)-mediated gene editing. NK cells from patients with STAT1 GOF mutations were treated in vitro with ruxolit

SUBMITTER: Vargas-Hernandez A 

PROVIDER: S-EPMC5924437 | biostudies-literature | 2018 Jun

REPOSITORIES: biostudies-literature